Dutch researchers write in the Journal of Clinical Psychopharmacology that, in a prospective study of 7415 persons with diagnoses of schizophrenia, use of a first-generation antipsychotic and use of a mood stabilizer were associated with higher mortality rates.
Read moreDiscuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
MAY add to mortality rate? Is this SERIOUSLY still in question???